HDAC6 has been identified as a major driver of ciliary disassembly, so several authors suggested that treatment with HDAC6 inhibitors may lead to increased length and number of PCs, concomitant with a suppression of tumor growth. This evidence concerns the gene HDAC6 and neoplasm.